Seeing Is Believing

Currently out of the existing stock ratings of Chris Howerton, 107 are a BUY (75.89%), 30 are a HOLD (21.28%), 4 are a SELL (2.84%).
Analyst Chris Howerton, carries an average stock price target met ratio of 54.96% that have a potential upside of 35.64% achieved within 273 days. Previously, Chris Howerton worked at JEFFERIES.
Chris Howerton’s has documented 281 price targets and ratings displayed on 44 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ARDX, Ardelyx at 02-Jan-2025.
Analyst best performing recommendations are on PSTI (PLURISTEM).
The best stock recommendation documented was for PSTI (PLURISTEM) at 12/10/2020. The price target of $6 was fulfilled within 1 day with a profit of $0.22 (3.54%) receiving and performance score of 35.37.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 09-May-2024
$29
$2.29 (8.57%)
$24
1 months 4 days ago
(02-Dec-2025)
10/14 (71.43%)
$3.57 (14.04%)
157
Buy
Since 10-Oct-2023
$31
$4.29 (16.06%)
$33
1 months 20 days ago
(17-Nov-2025)
8/14 (57.14%)
$6.98 (29.06%)
113
Buy
Since 28-Feb-2024
$29
$2.29 (8.57%)
$28
2 months ago
(06-Nov-2025)
5/11 (45.45%)
$7.35 (33.95%)
312
Buy
Since 23-Jun-2025
$32
$5.29 (19.81%)
$40
2 months ago
(06-Nov-2025)
0/3 (0%)
$10.35 (47.81%)
Buy
Since 07-Aug-2015
$39
$12.29 (46.01%)
$35
3 months 26 days ago
(11-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
What Year was the first public recommendation made by Chris Howerton?